Range Low Price High Price Comment
30 days $0.0717 $0.0997 Wednesday, 27th Mar 2024 BLCM stock ended at $0.0748. During the day the stock fluctuated 0% from a day low at $0.0748 to a day high of $0.0748.
90 days $0.0650 $0.200
52 weeks $0.0600 $1.31

Historical Bellicum Pharmaceuticals prices

Date Open High Low Close Volume
2022-03-30 $1.88 $1.98 $1.82 $1.93 19 845
2022-03-29 $1.91 $2.00 $1.89 $1.94 19 200
2022-03-28 $2.01 $2.05 $1.87 $1.87 22 800
2022-03-25 $2.05 $2.19 $2.03 $2.06 71 600
2022-03-24 $1.96 $2.07 $1.96 $2.01 35 600
2022-03-23 $2.06 $2.06 $1.92 $1.98 37 500
2022-03-22 $1.90 $2.10 $1.90 $2.05 25 223
2022-03-21 $2.05 $2.09 $1.86 $1.90 41 345
2022-03-18 $1.86 $2.00 $1.86 $2.00 64 579
2022-03-17 $1.76 $1.87 $1.74 $1.85 26 200
2022-03-16 $1.69 $1.79 $1.69 $1.74 19 300
2022-03-15 $1.60 $1.73 $1.60 $1.71 31 100
2022-03-14 $1.78 $1.79 $1.60 $1.62 39 300
2022-03-11 $1.72 $1.89 $1.70 $1.80 71 300
2022-03-10 $1.63 $1.72 $1.63 $1.69 38 700
2022-03-09 $1.53 $1.65 $1.53 $1.62 28 800
2022-03-08 $1.49 $1.54 $1.47 $1.48 18 700
2022-03-07 $1.50 $1.53 $1.48 $1.49 17 100
2022-03-04 $1.55 $1.60 $1.51 $1.53 67 000
2022-03-03 $1.59 $1.60 $1.52 $1.54 20 900
2022-03-02 $1.58 $1.68 $1.56 $1.59 14 200
2022-03-01 $1.68 $1.69 $1.56 $1.58 36 100
2022-02-28 $1.75 $1.85 $1.65 $1.70 65 500
2022-02-25 $1.65 $1.78 $1.65 $1.72 13 200
2022-02-24 $1.61 $1.68 $1.51 $1.65 25 900
Click to get the best stock tips daily for free!

About Bellicum Pharmaceuticals

Bellicum Pharmaceuticals Bellicum Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. The company's clinical product candidates include BPX-601, an autologous GoCAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of solid tumors expressing the prostate stem ce... BLCM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT